SynopsisDisposable syringe is a disposable medical appliance. A syringe is a simple piston pump consisting of a plunger that fits tightly in a tube. The plunger can be pulled and pushed along inside a cylindrical tube (the barrel), allowing the syringe to take in and .....
SynopsisThe global Paroxysmal Nocturnal Hemoglobinuria Treatment market was valued at US$ 3324.1 million in 2023 and is anticipated to reach US$ 5939.2 million by 2030, witnessing a CAGR of 8.5% during the forecast period 2024-2030. The global pharmaceutical mar.....
SynopsisMedical ESR (Erythrocyte Sedimentation Rate) Analyzers are specialized laboratory instruments used to measure the rate at which red blood cells settle in a tube over a specific period. The ESR is a non-specific marker of inflammation and is often used in conju.....
SynopsisThe global Toll Like Receptor 4 market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030. North American market for Toll Like Receptor 4 is estimated to increase.....
Synopsis The global Blood-Brain Barrier Transport Drugs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030. The global pharmaceutical market is 1.....
SynopsisThe global Tumor Necrosis Factor Receptor Superfamily Member 1A market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030. North American market for Tumor Necrosi.....
SynopsisA Remicade biosimilar is a biologic medication that is highly similar to Remicade, a brand-name biologic used to treat autoimmune diseases such as rheumatoid arthritis, Crohn's disease, and psoriasis. The global Remicade Biosimilar market was valued at U.....
SynopsisThe global Vasopressin V1b Receptor market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030. North American market for Vasopressin V1b Receptor is estimated to .....
SynopsisThe global Ornithine-Transcarbamylase Deficiency market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030. North American market for Ornithine-Transcarbamylase D.....
SynopsisSerum is the component that is neither a blood cell (serum does not contain white or red blood cells) nor a clotting factor; it is the blood plasma not including the fibrinogens. Serum includes all proteins not used in blood clotting (coagulation) and all the .....
